| Stage | USFD | % of rev | COR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.5B | 100.00% | $84.8B | 100.00% | COR ×8.05 |
| Gross profit | $1.9B | 18.22% | $3.6B | 4.26% | USFD +14.0pp |
| Operating income | $443M | 4.21% | $1.1B | 1.32% | USFD +2.9pp |
| Pre-tax income | $369M | 3.50% | $996M | 1.18% | USFD +2.3pp |
| Net income | $275M | 2.61% | $777M | 0.92% | USFD +1.7pp |
| Stage | USFD | COR | Gap · A − B |
|---|---|---|---|
| Revenue | $10.5B100.00% | $84.8B100.00% | COR ×8.05 |
| Gross profit | 18.22%$1.9B | 4.26%$3.6B | USFD +14.0pp |
| Operating income | 4.21%$443M | 1.32%$1.1B | USFD +2.9pp |
| Pre-tax income | 3.50%$369M | 1.18%$996M | USFD +2.3pp |
| Net income |
| 2.61%$275M |
| 0.92%$777M |
| USFD +1.7pp |
No shared counterparties.